Position in PFE
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$3,661,749
-$870,447 QoQ
Shares Held
152,066
-5.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#729
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. PFE ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
This page
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,661,749 | 152,066 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $4,532,196 | 161,403 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,018,785 | 161,397 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $4,421,417 | 173,525 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,997,224 | 164,902 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $3,932,945 | 155,207 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,380,766 | 165,125 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,905,127 | 169,493 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $4,741,602 | 169,464 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,817,872 | 137,581 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,850,057 | 133,729 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,091,287 | 123,343 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,741,036 | 129,254 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $4,510,480 | 110,551 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,677,801 | 110,808 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,885,541 | 111,644 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,897,536 | 112,484 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,860,571 | 113,204 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $7,079,032 | 119,882 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $5,333,110 | 123,997 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,716,587 | 120,444 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,335,716 | 119,672 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $4,439,617 | 120,609 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $4,365,790 | 118,959 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $4,317,352 | 132,029 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $3,984,294 | 122,068 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||